Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 18, 2013

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Abilify Maintena	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Zubsolv	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tivicay	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Linzess	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tecfidera	New Drug Appeal	Require Prior Approval	Prior Approval Required
Avonex	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Dulera	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Advair Diskus	PDL Appeal	Removed from Agenda	Prior Approval Required

Footer